Prospects for scaling-up supervised injection facilities in Canada: The role of evidence in legal and political decision-making

Addiction

Volumn 108, Issue 3, 2013, Pages 468-476

  Hyshka, Elaine ^a   Bubela, Tania ^a   Wild, T Cameron ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Canada; Evidence; Harm reduction; Illicit drug policy; Injection drug use; Law; Supervised injection facilities

Indexed keywords

ARTICLE; CANADA; DECISION MAKING; EVIDENCE BASED MEDICINE; HARM REDUCTION; HUMAN; LEGAL ASPECT; PREVENTIVE HEALTH SERVICE; SUBSTANCE ABUSE; LEGISLATION AND JURISPRUDENCE; REHABILITATION; SUPPLY AND DISTRIBUTION;

BRITISH COLUMBIA; DECISION MAKING; EVIDENCE-BASED MEDICINE; HARM REDUCTION; HUMANS; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84873994100     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12064     Document Type: Article

References (95)

1. Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., Hickman M. etal. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction 2006; 101: 1384-1393.
2. Bayoumi A. M., Strike C., Jairam J., Watson T., Enns E., Kolla G. etal. Report of the Toronto and Ottawa Supervised Consumption Assessment Study [document on the internet]. Toronto: University of Toronto; 2012. Available at: http://www.toscastudy.ca/toscastudy.ca/TOSCA_Report_files/TOSCA%20report-web.pdf (Archived at http://www.webcitation.org/6CihWqRg3 on 6 December 2012).
3. Kerr T., Kimber J., DeBeck K., Wood E. The role of safer injection facilities in the response to HIV/AIDS among injection drug users. Curr HIV/AIDS Rep 2007; 4: 158-164.
4. Hedrich D., Kerr T., Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T., Hedrich D., editors. Harm Reduction: Evidence, Impacts, and Challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2010, p. 306-331.
5. Degenhardt L., Mathers B., Vickerman P., Rhodes T., Latkin C., Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010; 376: 285-301.
6. Strathdee S. A., Navarro J. R. Commentary on Salmon etal. (2010): the case for safer inhalation facilities-waiting to inhale. Addiction 2010; 105: 684-685.
7. Campbell L., Boyd N., Culbert L. Vancouver's Downtown Eastside and the Fight for Its Future. Vancouver: Greystone; 2009.
8. Kerr T., MacPherson D., Wood E. Establishing North America's first safer injection facility: lessons from the Vancouver experience. In: Stevens A., editor. Crossing Frontiers: International Developments in the Treatment of Drug Dependence. Brighton: Pavilion Publishing; 2008, p. 109-129.
9. Wood E., Kerr T. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Policy 2006; 17: 55-60.
10. Vancouver Coastal Health. Supervised injection site: 2010 user statistics. Undated. Available at: http://supervisedinjection.vch.ca/research/supporting_research/user_statistics (Archived at http://www.webcitation.org/6CihhfFTV on 6 December 2012).
11. Goldstone I. What did it take to get Insite? Association of Registered Nurses of BC Weblog. 9 November, 2011. Available at: http://www.arnbc.ca/blog/what-did-it-take-to-get-insite/ (Archived at http://www.webcitation.org/6CihsR9dK on 6 December 2012).
12. Clement T. Do no harm, right? Globe and Mail 5 June, 2008.
13. Canada (Attorney General) v. PHS Community Services Society, (2011) SCC 44.
14. Makin K., Dhillon S., Peritz I. Supreme Court ruling opens doors to drug injection clinics across Canada. Globe and Mail 30 September, 2011. Available at: http://www.theglobeandmail.com/news/british-columbia/supreme-court-ruling-opens-doors-to-drug-injection-clinics-across-canada/article4182250/ (Archived at http://www.webcitation.org/6CihyR1OU on 6 December 2012).
15. Hainsworth J. Canada court lets drug-injection site stay open. Seattle Times 30 September, 2011. Available at: http://seattletimes.nwsource.com/html/health/2016371463_bcinject01.html (Archived at http://www.webcitation.org/6Cii5j11A on 6 December 2012).
16. Small D. Canada's highest court unchains injection drug users; implications for harm reduction as standard of healthcare. Harm Reduct J 2012; 9: 34.
17. Bains C. Doctors say court ruling on Insite opens door for similar facilities in Canada. 660 News 30 September, 2011. Available at: http://www.660news.com/news/national/article/283481-doctors-say-court-ruling-on-insite-opens-door-for-similar-facilities-in-canada (Archived at http://www.webcitation.org/6CiiRxdIp on 6 December 2012).
18. CBC News. Drug injection sites urged for Ottawa, Toronto. CBC News 11 April, 2012. Available at: http://www.cbc.ca/news/canada/ottawa/story/2012/04/11/ottawa-toronto-safe-injection-site-study-released.html (Archived at http://www.webcitation.org/6CiibP2iC on 6 December 2012).
19. MacQueen K., Patriquin M. Are we ready to subsidize heroin? Macleans.ca. 7 October, 2011. Available at: http://www2.macleans.ca/2011/10/07/are-we-ready-to-subsidize-heroin/ (Archived at http://www.webcitation.org/6CiijMxhV on 6 December 2012).
20. Mennie J. Montreal seeks drug injection sites at hospitals, clinics. National Post 20 October, 2011. Available at: http://news.nationalpost.com/2011/10/20/montreal-seeks-drug-injection-sites-at-hospitals-clinics/ (Archived at http://www.webcitation.org/6CiioqE3Z on 6 December 2012).
21. Agarwal R. P. Case comment: Canada (Attorney General) v. PHS Community Services Society. Const Forum 2011; 20: 1-48.
22. Boyd S. C., MacPherson D., Osborn B. Raise Shit! Social Action Saving Lives. Winnipeg: Fernwood Publishing; 2009.
23. Dooling K., Rachlis M. Vancouver's supervised injection facility challenges Canada's drug laws. Can Med Assoc J 2010; 182: 1440-1444.
24. Small D., Palepu A., Tyndall M. W. The establishment of North America's first state sanctioned supervised injection facility: a case study in culture change. Int J Drug Policy 2006; 17: 73-82.
25. Miller C. L., Chan K. J., Palepu A., Tyndall M., Wood E., Hogg R. etal. Socio-demographic profile and HIV and Hepatitis C prevalence among persons who died of a drug overdose. Addict Res Theory 2001; 9: 459-470.
26. Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S. etal. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11: F59-65.
27. Hyshka E., Strathdee S., Wood E., Kerr T. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy 2012; 23: 261-270.
28. Kerr T., Oleson M., Tyndall M. W., Montaner J., Wood E. A description of a peer-run supervised injection site for injection drug users. J Urban Health 2005; 82: 267-275.
29. Small W., Shoveller J., Moore D., Tyndall M., Wood E., Kerr T. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res 2011; 21: 743-756.
30. Small W., Wood E., Lloyd-Smith E., Tyndall M., Kerr T. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug Alcohol Depend 2008; 98: 159-162.
31. Graham J. Supervised injection sites-a view from law enforcement. BC Med J 2008; 50: 132-134.
32. DeBeck K., Wood E., Zhang R., Tyndall M., Montaner J., Kerr T. Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility. Subst Abuse Treat Prev Policy 2008; 3: 11.
33. Wood E., Kerr T., Montaner J. S., Strathdee S. A., Wodak A., Hankins C. A. etal. Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis 2004; 4: 301-306.
34. Milloy M.-J. S., Kerr T., Mathias R., Zhang R., Montaner J. S., Tyndall M. etal. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse 2008; 34: 499-509.
35. Wood E., Kerr T., Small W., Li K., Marsh D. C., Montaner J. S. G. etal. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Can Med Assoc J 2004; 171: 731-734.
36. Kerr T., Tyndall M. W., Zhang R., Lai C., Montaner J. S. G., Wood E. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health 2007; 97: 1228-1230.
37. Controlled Drugs and Substances Act, c. 19, ss. 4(1) and 5(1). S.C. 1996. Available at: http://laws-lois.justice.gc.ca/eng/acts/C-38.8/ (Archived at http://www.webcitation.org/6CiiznXe5 on 6 December 2012).
38. R v. Parker, (2000) 188D.L.R. (4th) 385.
39. PHS Community Services Society v. Attorney General of Canada, (2008) BCSC 661, 85 B.C.L.R. (4th) 89, 158-159.
40. Wood E., Tyndall M. W., Li K., Lloyd-Smith E., Small W., Montaner J. S. G. etal. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med 2005; 29: 126-130.
41. Kerr T., Tyndall M., Li K., Montaner J., Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005; 366: 316-318.
42. Wood E., Tyndall M., Stoltz J., Small W., Lloyd-Smith E., Zhang R. Factors associated with syringe sharing among users of a medically supervised safer injecting facility. Am J Infect Dis 2005; 1: 50-54.
43. Stoltz J.-A., Wood E., Small W., Li K., Tyndall M., Montaner J. etal. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf) 2007; 29: 35-39.
44. Petrar S., Kerr T., Tyndall M. W., Zhang R., Montaner J. S. G., Wood E. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility. Addict Behav 2007; 32: 1088-1093.
45. Fairbairn N., Small W., Shannon K., Wood E., Kerr T. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility. Soc Sci Med 2008; 67: 817-823.
46. Fast D., Small W., Wood E., Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduct J 2008; 5: 32.
47. Kerr T., Small W., Moore D., Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. Int J Drug Policy 2007; 18: 37-45.
48. Wood E., Tyndall M. W., Montaner J. S., Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Can Med Assoc J 2006; 175: 1399-1404.
49. Wood E., Tyndall M. W., Zhang R., Montaner J. S. G., Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 2007; 102: 916-919.
50. Tyndall M. W., Kerr T., Zhang R., King E., Montaner J. G., Wood E. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend 2006; 83: 193-198.
51. Wood E., Tyndall M. W., Qui Z., Zhang R., Montaner J. S. G., Kerr T. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Public Health 2006; 96: 770-773.
52. DeBeck K., Kerr T., Bird L., Zhang R., Marsh D., Tyndall M. etal. Injection drug use cessation and use of North America's first medically supervised safer injecting facility. Drug Alcohol Depend 2011; 113: 172-176.
53. Kerr T., Stolz J.-A., Tyndall M., Li K., Zhang R., Montaner J. etal. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ 2006; 332: 220-222.
54. Rachlis B. S., Hogg R. S., Wood E., Li K., Kerr T. Factors associated with geographic migration among a cohort of injection drug users. Health Place 2008; 14: 536-543.
55. Kerr T., Tyndall M. W., Lai C., Montaner J. S. G., Wood E. Drug-related overdoses within a medically supervised safer injection facility. Int J Drug Policy 2006; 17: 436-441.
56. Marshall B. D. L., Milloy M.-J., Wood E., Montaner J. S. G., Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet 2011; 377: 1429-1437.
57. Andresen M. A., Boyd N. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. Int J Drug Policy 2010; 21: 70-76.
58. Des Jarlais D. C., Arasteh K., Hagan H. Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics. Can Med Assoc J 2008; 179: 1105-1106.
59. Pinkerton S. D. Is Vancouver Canada's supervised injection facility cost-saving? Addiction 2010; 105: 1429-1436.
60. Pinkerton S. D. How many HIV infections are prevented by Vancouver Canada's supervised injection facility? Int J Drug Policy 2011; 22: 179-183.
61. Lloyd C., Godfrey C. Commentary on Pinkerton (2010): drug consumption rooms-time to accept their worth. Addiction 2010; 105: 1437-1438.
62. Bayoumi A. M., Zaric G. S. The cost-effectiveness of Vancouver's supervised injection facility. Can Med Assoc J 2008; 179: 1143-1151.
63. Wood E., Kerr T., Lloyd-Smith E., Buchner C., Marsh D. C., Montaner J. S. G. etal. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004; 1: 9.
64. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998; 51: 253-263.
65. Hall W., Kimber J. Being realistic about benefits of supervised injecting facilities. Lancet 2005; 366: 271-272.
66. Stoever H. Consumption rooms-a middle ground between health and public order concerns. J Drug Issues 2002; 32: 597-606.
67. Expert Advisory Committee. Vancouver's INSITE service and other supervised injection sites: what has been learned from research? Final report. Ottawa: Health Canada; 2008. Available at: http://www.hc-sc.gc.ca/ahc-asc/pubs/_sites-lieux/insite/index-eng.php (Archived at http://www.webcitation.org/6Ck7VUBxj on 6 December 2012).
68. Mangham C. A critique of Canada's INSITE injection site and its parent philosophy: implications and recommendations for policy planning. J Global Drug Policy Pract 2007; 1. Available at: http://www.globaldrugpolicy.org/Issues/Vol%201%20Issue%202/A%20critique%20of%20Canada's%20INSITE.pdf (Archived at http://www.webcitation.org/6Ck7fjOUP on 6 December 2012).
69. Wood E., Kerr T., Tyndall M. W., Montaner J. S. G. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Int J Drug Policy 2008; 19: 220-225.
70. Hyshka E., Butler-McPhee J., Elliott R., Wood E., Kerr T. Canada moving backwards on illegal drugs. Can J Public Health 2012; 103: 125-127.
71. Canadian Charter of Rights and Freedoms, s.7, Part I of the Constitution Act, 1982, being Schedule B to the Canada Act 1982 (UK), 1982, c 11. Available at: http://laws-lois.justice.gc.ca/eng/Const/page-15.html (Archived at http://www.webcitation.org/6Ck7kbb5N on 6 December 2012).
72. PHS Community Services Society v. Canada (Attorney General), (2010) BCCA 15.
73. Makin K. Landmark Insite decision threatens peace between judges and legislators. Globe and Mail 10 October, 2011. Available at: http://www.theglobeandmail.com/news/politics/landmark-insite-decision-threatens-peace-between-judges-and-legislators/article557654/ (Archived at http://www.webcitation.org/6Ck80h3zm on 6 December 2012).
74. Marihuana Medical Access Regulations, SOR/2001-227. 2001. Available at: http://canlii.ca/t/l6d2 (accessed 28 August 2012).
75. Bubela T. Expert evidence: the ethical responsibility of the legal profession. Alta Law Rev 2004; 41: 853-870.
76. R. v. J.-L.J., 2000 SCC 51, (2000) 2 S.C.R. 600.
77. Wood R. A., Zettel P., Stewart W. The Dr. Peter Centre: harm reduction nursing. Can Nurse 2003; 99: 20-24.
78. Davis M. Dr. Peter Centre a legal and professional model for Insite. Vancouver Sun 4 September, 2007. Available at: http://www.canada.com/story_print.html?id=9c95fa4c-9e0d-4113-b7c8-8cbf4c1e9545&sponsor= (Archived at http://www.webcitation.org/6Ck8Av2LF on 6 December 2012).
79. College of Registered Nurses of British Columbia. Scope of practice for registered nurses: standards, limits, and conditions. 11 March, 2012. Available at: https://www.crnbc.ca/Standards/Lists/StandardResources/433ScopeforRegisteredNurses.pdf (accessed 28 August 2012).
80. Dr. Peter AIDS Foundation. Factum of the intervener Dr. Peter AIDS Foundation submitted to the Supreme Court of Canada. S.C.C. File no. 3356. 12 April, 2011. Available at: http://www.aspercentre.ca/constitutional-cases/scc-facta/alpha-list-cases/canada_v_phs-community-services.htm (Archived at http://www.webcitation.org/6Ck8EBv6B on 6 December 2012).
81. D'Angelo A. M. Harm reduction program benefits many at North America's only supervised injection site. Hospital News 7 March, 2012. Available at: http://www.hospitalnews.com/harm-reduction-program-benefits-many-at-north-america%E2%80%99s-only-supervised-injection-site/ (Archived at http://www.webcitation.org/6Ck8bkJxS on 6 December 2012).
82. Mehler Paperny A. Ottawa, Toronto resist call for supervised injection sites. Globe and Mail 12 April, 2012. Available at: http://www.theglobeandmail.com/news/politics/ottawa-toronto-resist-call-for-supervised-injection-sites/article2398395/ (Archived at http://www.webcitation.org/6Ck8rHafj on 6 December 2012).
83. Geddes J. RCMP and the truth about safe injection sites. Macleans.ca 20 August, 2010. Available at: http://www2.macleans.ca/2010/08/20/injecting-truth/ (Archived at http://www.webcitation.org/6Ck8yJPms on 6 December 2012).
84. Royal Canadian Mounted Police. Contract policing [webpage on the Internet]. 28 October, 2011. Available at: http://www.rcmp-grc.gc.ca/ccaps-spcca/contract-eng.htm (Archived at http://www.webcitation.org/6Ck9JupCm on 6 December 2012).
85. Christie T., Wood E., Schechter M. T., O'Shaughnessy M. V. A comparison of the new federal guidelines regulating supervised injection site research in Canada and the Tri-Council policy statement on ethical conduct for research involving human subjects. Int J Drug Policy 2004; 15: 66-73.
86. Conway M. Supervised injection sites: is the Supreme Court of Canada's decision off-target? McGill Journal of Law and Health Blog 20 January, 2012. Available at: http://mjlh.mcgill.ca/blog.php?blog_id=33 (Archived at http://www.webcitation.org/6Ck9ovG7S on 6 December 2012).
87. Urban Health Research Institute. Initiatives [webpage on the Internet]. Undated. Available at: http://www.cfenet.ubc.ca/research/uhri/initiatives (Archived at http://www.webcitation.org/6Ck9ujlJs on 6 December 2012).
88. Fischer B., Rehm J., Patra J., Kalousek K., Haydon E., Tyndall M. etal. Crack across Canada: comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006; 101: 1760-1770.
89. Fischer B., Rehm J., Brissette S., Bruneau J., El-Guebaly N., Noël L. etal. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 2005; 82: 250-266.
90. Public Health Agency of Canada. I-Track: Enhanced Surveillance of Risk Behaviours among People Who Inject Drugs. Phase I Report. Ottawa: Public Health Agency of Canada; 2006. Available at: http://www.phac-aspc.gc.ca/i-track/sr-re-1/pdf/itrack06_e.pdf (Archived at http://www.webcitation.org/6CkA0S1vw on 6 December 2012).
91. Kimber J., Dolan K., Van Beek I., Hedrich D., Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev 2003; 22: 227-233.
92. Dolan K., Kimber J., Fry C., McDonald D., Fitzgerald J., Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev 2000; 19: 337-346.
93. Hunt N. An overview of models of drug consumption rooms. Independent Working Group on Drug Consumption Rooms. York: Joseph Rowntree Foundation; 2006. Available at: http://www.jrf.org.uk/sites/files/jrf/Hunt-DCR-C.pdf (Archived at http://www.webcitation.org/6CkA6v6W5 on 6 December 2012).
94. Lane S. D., Lurie P., Bowser B., Khan J., Chen D. The coming of age of needle exchange: a history through 1993. In: Incardi J. A., Harrison L. D., editors. Harm Reduction: National and International Perspectives. Thousand Oaks, CA: Sage; 2000, p. 47-68.
95. Macfarlane E. Failing to walk the rights talk-post-9/11 security policy and the Supreme Court of Canada. Rev Const Stud 2012; 16: 159-180.